The newcleo Nasdaq listing is set to begin on September 22 after the advanced nuclear company completed its combination with NewHold Investment Corp III. Ordinary shares of newcleo (NASDAQ: NWCL) and warrants are expected to trade on the Nasdaq Global Select Market.
The transaction provided approximately $247 million in gross proceeds. That total included a $216 million private investment in public equity and $31 million remaining in NewHold’s trust account at closing.
newcleo Nasdaq Listing Values Company at $2.4 Billion
The business combination assigned newcleo a pre-money equity value of approximately $2.4 billion, according to the company’s official closing announcement. NewHold shareholders approved the transaction at a September 17 meeting.
An additional amount of up to $75 million may become available under a previously disclosed forward-purchase agreement. Because that capital is conditional, it is separate from the $247 million received at closing.
Existing newcleo shareholders rolled over all of their equity. The company’s management will remain in place, while former power-industry executive Jeffrey Lyash will chair the public-company board.
Capital Will Fund Reactor and Nuclear-Fuel Development
newcleo plans to use the proceeds to advance its lead-cooled fast-reactor technology and mixed-oxide nuclear-fuel operations in the United States and Europe. Near-term work includes a 10-megawatt thermal non-nuclear demonstrator in Italy and regulatory engagement with U.S. and French authorities.
Mixed-oxide fuel can incorporate recycled nuclear material, while a lead-cooled reactor uses liquid metal rather than water as its primary coolant. Both concepts still require extensive testing, licensing and industrial-scale manufacturing before they can support routine commercial generation.
The listing gives public investors access to a developer at a pre-commercial stage. Reactor licensing, demonstration performance, capital requirements and construction schedules remain substantial risks, and the transaction proceeds do not remove the need for future execution.
Trading performance may also be volatile as the former SPAC establishes a public-market shareholder base. The most important operational milestones will be licensing progress, successful demonstrations and evidence that planned fuel and reactor facilities can move toward commercial deployment.
